已发表论文

胃癌多药耐药机制研究的进展综述

 

Authors Ruan T, Liu W, Tao K, Wu C

Received 20 November 2019

Accepted for publication 15 February 2020

Published 28 February 2020 Volume 2020:13 Pages 1797—1807

DOI https://doi.org/10.2147/OTT.S239336

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Takuya Aoki

Abstract: Gastric cancer is one of the most common malignant tumors, and it is also one of the leading causes of cancer death worldwide. Because of its insidious symptoms and lack of early dictation screening, many cases of gastric cancer are at late stages which make it more complicated to cure. For these advanced-stage gastric cancers, combination therapy of surgery, chemotherapy, radiotherapy and target therapy would bring more benefit to the patients. However, the drug-resistance to the chemotherapy restricts its effect and might lead to treatment failure. In this review article, we discuss the mechanisms which have been found in recent years of drug resistance in gastric cancer. And we also want to find new approaches to counteract chemotherapy resistance and bring more benefits to the patients.
Keywords: gastric cancer, chemotherapy, resistance




Figure 1 The summary of mechanisms of drug resistance in gastric cancer.